| Literature DB >> 24649403 |
Takenobu Nii1, Tomotoshi Marumoto2, Hirotaka Kawano1, Saori Yamaguchi1, Jiyuan Liao1, Michiyo Okada1, Erika Sasaki3, Yoshie Miura1, Kenzaburo Tani2.
Abstract
Common marmoset (CM) is widely recognized as a useful non-human primate for disease modeling and preclinical studies. Thus, embryonic stem cells (ESCs) derived from CM have potential as an appropriate cell source to test human regenerative medicine using human ESCs. CM ESCs have been established by us and other groups, and can be cultured in vitro. However, the growth factors and downstream pathways for self-renewal of CM ESCs are largely unknown. In this study, we found that basic fibroblast growth factor (bFGF) rather than leukemia inhibitory factor (LIF) promoted CM ESC self-renewal via the activation of phosphatidylinositol-3-kinase (PI3K)-protein kinase B (AKT) pathway on mouse embryonic fibroblast (MEF) feeders. Moreover, bFGF and transforming growth factor β (TGFβ) signaling pathways cooperatively maintained the undifferentiated state of CM ESCs under feeder-free condition. Our findings may improve the culture techniques of CM ESCs and facilitate their use as a preclinical experimental resource for human regenerative medicine.Entities:
Keywords: AKT, protein kinase B; CM, common marmoset; Common marmoset; EB, embryoid body; ERK, extracellular signal-regulated kinase; ESCs, embryonic stem cells; Embryonic stem cells; EpiSCs, epiblast stem cells; FCM, flow cytometry; JAK, janus kinase; KSR, knockout serum replacement; LIF, leukemia inhibitory factor; MEFs, mouse embryonic fibroblasts; MEK, mitogen-activated protein/extracellular signal-regulated kinase kinase; PI3K, phosphatidylinositol-3-kinase; RT-PCR, reverse transcription-polymerase chain reaction; SMAD2/3, mothers against decapentaplegic homolog 2/3; STAT3, signal transducer and activator of transcription 3; Self-renewal; TGFβ; TGFβ, transforming growth factor β; bFGF; bFGF, basic fibroblast growth factor; iPSCs, induced pluripotent stem cells
Year: 2014 PMID: 24649403 PMCID: PMC3958738 DOI: 10.1016/j.fob.2014.02.007
Source DB: PubMed Journal: FEBS Open Bio ISSN: 2211-5463 Impact factor: 2.693
Fig. 1bFGF promotes self-renewal of CM ESCs in the presence of feeder support. (A) RT-PCR analysis showing the expression of FGFR1, FGFR2, FGFR3, FGFR4, LIFR, and gp130 genes in CM ESCs (CM40). (B) No effect of bFGF on the proportion of OCT3/4+ cells. CM ESCs (CM40; 1.4 × 105) were seeded on mitomycin C (MMC)-treated MEFs and cultured with LIF (open square), bFGF (open circle), or without growth factors (control; open triangle). The percentage of OCT3/4+ cells was determined by FCM. (C) Enhancement of undifferentiated CM ESC growth by bFGF. CM ESCs (CM40; 1.4 × 105) were seeded on mitomycin C (MMC)-treated MEFs and cultured with LIF (open square), bFGF (open circle), or without growth factors (control; open triangle). The number of cells was then counted by trypan blue exclusion. The number of OCT3/4+ cells was determined by multiplying the number of cells by the percentage of OCT3/4+ cells and the passage ratio together. Data are shown as the mean ± SD (n = 4). ∗∗P < 0.01 (bFGF vs. control) and ††P < 0.01 (bFGF vs. LIF). Note that all of PCR in (A) was performed with 30 cycles, and no bands were detected for FGFR expression in MEFs in (A), however, they were faintly done when PCR was performed with 40 cycles.
Fig. 2bFGF-PI3K-AKT pathway supports self-renewal of CM ESCs. (A) Western blot analysis showing the activation of AKT by bFGF in CM ESCs. CM40 cells were starved of bFGF and KSR overnight, and then stimulated with 5 ng/ml of bFGF for the indicated durations. AKT, ERK1/2 and α-Tubulin are shown as loading controls. The relative band intensities of p-AKT/AKT and p-ERK/ERK are shown in (B). Band intensities were measured by ImageJ software. Data are shown as the mean ± SD. The Student’s t-test was used to test inter-group differences. ∗∗P < 0.01. (C) Inhibition of self-renewal by LY294002. CM ESCs (CM40; 1.4 × 105) were seeded on MMC-treated MEFs and cultured in medium containing bFGF (open circle), control medium (open triangle), bFGF+LY294002 (closed circle) or LY294002 (closed triangle). The percentage of OCT3/4+ cells was then determined by FCM at the indicated day as shown in (C). The number of live cells was counted by trypan blue exclusion. Growth curves were generated by multiplying the number of live cells by the percentage of OCT3/4+ cells and passage ratio together as shown in (D). Data are shown as the mean ± SD. bFGF, n = 4; control, n = 4; bFGF+LY294002, n = 3; LY294002, n = 3; ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.005, bFGF vs. control; ††P < 0.01 and †††P < 0.005, bFGF+LY294002 or LY294002 vs. control.
Fig. 3bFGF and TGFβ maintain the undifferentiated state of CM ESCs under feeder-free conditions. (A) Western blot showing the activation of AKT, ERK1/2 and SMAD2/3 by 100 ng/ml of bFGF or 2 ng/ml of TGFβ for 30 min in CM ESCs. CM40 were starved of growth factors overnight and then pre-treated with LY294002 or PD0325901for 1 h before stimulation with bFGF. AKT, ERK1/2, SMAD2/3, and α-Tubulin are shown as loading controls. The relative band intensities of p-AKT/AKT, p-ERK/ERK and p-SMAD2/3/SMAD2/3 are shown in (B). Band intensities were measured by ImageJ software. Data are shown as the mean±SD. One-way ANOVA followed by the Tukey’s post-hoc test was used to test inter-group differences. ∗∗P < 0.01 and ∗∗∗P < 0.005. (C) Immunocytochemical analyses of NANOG expression in CM ESCs (CM40) cultured with various growth factors for 4 days. Merged images of NANOG (red) and nuclei (DAPI; blue) are shown. Scale bars represent 200 μm. NANOG expression in cells cultured without any growth factors is shown as a control. (D) Proportion of NANOG+ colonies. The percentage of NANOG+ colonies cultured with various growth factors was analyzed by immunocytochemistry. For statistical analyses, 300 colonies were examined in each experiment (n = 3). Data are shown as the mean ± SD. One-way ANOVA followed by the Tukey’s post-hoc test was used to test inter-group differences. ∗∗∗P < 0.005. The difference between bFGF- and bFGF+TGFβ-treated cells was statistically analyzed using the Student’s t-test. ††P < 0.01.
The characters of mouse EpiSCs and mouse, human and CM ESCs.
| Mouse ESCs | Mouse EpiSCs | Human ESCs | CM ESCs | ||
|---|---|---|---|---|---|
| Morphology of colony | Small, dome | Large, flat | Large, flat | Large, flat | |
| Growth factor dependency | LIF | + | − | − | − |
| bFGF | − | + | + | + | |
| TGFβ/activin | − | + | + | + | |
| Marker expression | NANOG | + | + | + | + |
| OCT3/4 | + | + | + | + | |
| T (brachyury) | − | + | + | + | |
| CER1 | − | + | + | + | |
| EOMES | − | + | + | + | |
| FOXA2 | − | + | + | + | |
| GATA6 | − | + | + | + | |
| SOX17 | − | + | + | + | |
| Tolerance to single cell dissociation | + | − | − | − | |
| Contribution in chimera | + | − | N/D | N/D |
N/D = not determined.